EUVIMEDEUVIMED entdecken
Crossref

A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated Fibroblasts

Hisanobu Ogata, Akira Imaizumi, Yutaka Fujioka, Hiroyuki Shimizu, Yusuke Hirata, Atsushi Matsuzawa, Toshihisa Tsuruta, Hiroaki Niiro, Hideya Onishi, Masafumi Nakamura, Kenzaburo Tani

Anticancer Research · 2024

DOI: 10.21873/anticanres.17348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Hisanobu Ogata und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Education Center, Kyushu University Hospital, Fukuoka, Japan; hogata@kyudai.jp. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Oncolytic Virotherapy, Cancer-Associated Fibroblasts, Enterovirus B, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Pancreatic cancer is a major cause of mortality in the world. It is one of most aggressive diseases, with a 5-year survival rate of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsOncolytic VirotherapyCancer-Associated FibroblastsEnterovirus B, HumanOncolytic VirusesHumansCell Line, Tumor

Stichwörter der Autor:innen

Pancreatic cancercancer-associated fibroblastcoxsackievirusoncolytic virus

Autor:innen und Institutionen

  • Clinical Education Center, Kyushu University Hospital, Fukuoka, Japan; hogata@kyudai.jp.
  • Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.

Zitieren

APA

Ogata, H., Imaizumi, A., Fujioka, Y., Shimizu, H., Hirata, Y., Matsuzawa, A., Tsuruta, T., Niiro, H., Onishi, H., Nakamura, M., & Tani, K. (2024). A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated Fibroblasts. Anticancer Research. https://doi.org/10.21873/anticanres.17348

Vancouver

Ogata H, Imaizumi A, Fujioka Y, Shimizu H, Hirata Y, Matsuzawa A, et al. A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated Fibroblasts. Anticancer Research. 2024. doi:10.21873/anticanres.17348

BibTeX
@article{Ogata2024,
  author = {Ogata, Hisanobu and Imaizumi, Akira and Fujioka, Yutaka and Shimizu, Hiroyuki and Hirata, Yusuke and Matsuzawa, Atsushi and Tsuruta, Toshihisa and Niiro, Hiroaki and Onishi, Hideya and Nakamura, Masafumi and Tani, Kenzaburo},
  title = {A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated Fibroblasts},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17348}
}
Kostenlos starten →